325 related articles for article (PubMed ID: 12833647)
1. Small molecule inhibitors of cell signaling: novel future therapeutics for asthma and chronic obstructive pulmonary diseases.
Blease K; Raymon HK
Curr Opin Investig Drugs; 2003 May; 4(5):544-51. PubMed ID: 12833647
[TBL] [Abstract][Full Text] [Related]
2. Defective apoptotic cell clearance in asthma and COPD--a new drug target for statins?
Walsh GM
Trends Pharmacol Sci; 2008 Jan; 29(1):6-11. PubMed ID: 18054798
[TBL] [Abstract][Full Text] [Related]
3. New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy.
Onoue S; Misaka S; Kawabata Y; Yamada S
Expert Opin Drug Deliv; 2009 Aug; 6(8):793-811. PubMed ID: 19558334
[TBL] [Abstract][Full Text] [Related]
4. Emerging oligonucleotide therapies for asthma and chronic obstructive pulmonary disease.
Séguin RM; Ferrari N
Expert Opin Investig Drugs; 2009 Oct; 18(10):1505-17. PubMed ID: 19715448
[TBL] [Abstract][Full Text] [Related]
5. Agents against cytokine synthesis or receptors.
Yamagata T; Ichinose M
Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805
[TBL] [Abstract][Full Text] [Related]
6. Rho kinase as a therapeutic target in the treatment of asthma and chronic obstructive pulmonary disease.
Fernandes LB; Henry PJ; Goldie RG
Ther Adv Respir Dis; 2007 Oct; 1(1):25-33. PubMed ID: 19124345
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological treatment in asthma and COPD.
Hoshino T; Toda R; Aizawa H
Allergol Int; 2009 Sep; 58(3):341-6. PubMed ID: 19628978
[TBL] [Abstract][Full Text] [Related]
8. Handle with care: targeting neutrophils in chronic obstructive pulmonary disease and severe asthma?
Beeh KM; Beier J
Clin Exp Allergy; 2006 Feb; 36(2):142-57. PubMed ID: 16433851
[TBL] [Abstract][Full Text] [Related]
9. Airway nitrergic pathways: is there therapeutic potential in asthma and COPD?
Folkerts G; Nijkamp FP
Curr Opin Pharmacol; 2004 Jun; 4(3):202-6. PubMed ID: 15140409
[TBL] [Abstract][Full Text] [Related]
10. Bioactive analogues and drug delivery systems of vasoactive intestinal peptide (VIP) for the treatment of asthma/COPD.
Onoue S; Yamada S; Yajima T
Peptides; 2007 Sep; 28(9):1640-50. PubMed ID: 17537541
[TBL] [Abstract][Full Text] [Related]
11. Biologic and pharmacologic therapies in clinical development for the inflammatory response in COPD.
Morjaria JB; Malerba M; Polosa R
Drug Discov Today; 2010 May; 15(9-10):396-405. PubMed ID: 20223295
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-9 as a possible therapeutic target in both asthma and chronic obstructive airways disease.
McNamara PS; Smyth RL
Drug News Perspect; 2005 Dec; 18(10):615-21. PubMed ID: 16491163
[TBL] [Abstract][Full Text] [Related]
13. Current and future therapies for airway mucus hypersecretion.
Barnes PJ
Novartis Found Symp; 2002; 248():237-49; discussion 249-53, 277-82. PubMed ID: 12568498
[TBL] [Abstract][Full Text] [Related]
14. Aerosolized phosphoinositide 3-kinase gamma/delta inhibitor TG100-115 [3-[2,4-diamino-6-(3-hydroxyphenyl)pteridin-7-yl]phenol] as a therapeutic candidate for asthma and chronic obstructive pulmonary disease.
Doukas J; Eide L; Stebbins K; Racanelli-Layton A; Dellamary L; Martin M; Dneprovskaia E; Noronha G; Soll R; Wrasidlo W; Acevedo LM; Cheresh DA
J Pharmacol Exp Ther; 2009 Mar; 328(3):758-65. PubMed ID: 19056934
[TBL] [Abstract][Full Text] [Related]
15. Statins as emerging treatments for asthma and chronic obstructive pulmonary disease.
Walsh GM
Expert Rev Respir Med; 2008 Jun; 2(3):329-35. PubMed ID: 20477197
[TBL] [Abstract][Full Text] [Related]
16. Immunology of asthma and chronic obstructive pulmonary disease.
Barnes PJ
Nat Rev Immunol; 2008 Mar; 8(3):183-92. PubMed ID: 18274560
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy.
Kirkham P; Rahman I
Pharmacol Ther; 2006 Aug; 111(2):476-94. PubMed ID: 16458359
[TBL] [Abstract][Full Text] [Related]
18. Clinical management of chronic obstructive pulmonary disease and asthma in an obese patient.
Lessard A; Maltais F; Boulet LP
Expert Opin Pharmacother; 2008 Jan; 9(1):83-93. PubMed ID: 18076340
[TBL] [Abstract][Full Text] [Related]
19. Emerging treatments for asthma.
Blease K; Lewis A; Raymon HK
Expert Opin Emerg Drugs; 2003 May; 8(1):71-81. PubMed ID: 14610913
[TBL] [Abstract][Full Text] [Related]
20. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
